Dr Reddys Laboratories appoints Milan Kalawadia as CEO - North America Dr Reddys Laboratories has informed that Mr. Marc Kikuchi has resigned from the role of CEO of North America Generics. He will cease to be a member of the Management Council and Senior Management Personnel of the company, effective from the close of working hours on May 24, 2024. Mr. Milan Kalawadia, currently Chief Commercial Officer- North America Generics is elevated to the role of CEO - North America and is also inducted as a Member of the Management Council and Senior Management Personnel of the company, effective from May 25, 2024. Also, company and Nestle India have entered into a joint venture agreement for investment in Dr. Reddys Nutraceuticals Limited.
MARKET VIEW
OUTLOOK
SECTORS
STRATEGY
VIEW
PERSONAL FINANCE
INSURANCE
INVEST
MUTUAL FUND
GENERAL